Erythema multiforme-like hypersensitivity reaction to infliximab: an atypical and refractory case

Eur J Dermatol. 2019 Jun 1;29(3):334-336. doi: 10.1684/ejd.2019.3548.

Authors

Takuya Mizukami¹, Yasuyuki Fujita¹, Shoko Mai¹, Hajime Miyazawa¹, Toshinari Miyauchi¹, Ken Muramatsu¹, Takehiko Katsurada², Hitoshi Kobayashi³, Hiroshi Shimizu¹

Affiliations

¹ Department of Dermatology, Hokkaido University Graduate School of Medicine.
² Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine.
³ Kobayashi Dermatology Clinic, Sapporo, Hokkaido, Japan.

PMID: 31281115
DOI: 10.1684/ejd.2019.3548

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Drug Eruptions / etiology*
Erythema Multiforme / chemically induced*
Humans
Infliximab / adverse effects*
Male
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Tumor Necrosis Factor-alpha
Infliximab